CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $247,000 | -12.1% | 3,000 | 0.0% | 0.01% | -13.3% |
| Q2 2017 | $281,000 | -26.4% | 3,000 | -50.0% | 0.02% | -25.0% |
| Q1 2017 | $382,000 | +43.1% | 6,000 | 0.0% | 0.02% | +33.3% |
| Q4 2016 | $267,000 | +23.6% | 6,000 | 0.0% | 0.02% | +25.0% |
| Q3 2016 | $216,000 | +2.9% | 6,000 | 0.0% | 0.01% | +9.1% |
| Q4 2015 | $210,000 | -62.0% | 6,000 | 0.0% | 0.01% | -63.3% |
| Q3 2015 | $552,000 | +4.7% | 6,000 | 0.0% | 0.03% | +11.1% |
| Q2 2015 | $527,000 | – | 6,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |